TY - CONF T1 - Combination vs single agent treatment: The effects of zoledronic acid+/鈭抎oxorubicin on breast tumour growth in bone prior to development of osteolytic bone disease JO - Bone PY - 2011/01/01 AU - Brown* HK AU - Ottewell PD AU - Evans CA AU - Coleman RE AU - Holen I ED - DO - DOI: 10.1016/j.bone.2010.10.116 PB - Elsevier BV VL - 48 IS - 1 SP - S41 EP - S41 Y2 - 2025/08/13 ER -